Clinical Trials Logo

Clinical Trial Summary

This study is aimed at studying the efficacy and safety of treating chronic anal fissure with botulinum toxin versus lateral subcutaneous sphincterotomy.


Clinical Trial Description

Chronic anal fissure is a rupture of anal canal mucosa lasting for more than 2 months and resistant to non-surgical treatment. This condition is attended by severe pain syndrome during and after bowel movement (defecation). This condition is most frequent in younger and working-age adults; therefore, the treatment issue is of particular relevance. The main cause of chronic anal fissure development is spasm of the internal sphincter. It should be eliminated in the first instance, in order to provide the effective therapy. All the main treatment methods, such as medicinal relaxation of the internal sphincter with 0.4% nitroglycerin ointment, lateral subcutaneous sphincterotomy, and pneumodivulsion of the anal sphincter are aimed at its removal. However, the optimal method has not yet been developed. Non-surgical treatments are often attended by relapse of disease, while surgical treatment is often complicated by intestinal contents incontinence, usually gas and loose or hard stool in some occasions (grade 3 anal sphincter insufficiency). In particular, lateral subcutaneous sphincterotomy performed in such patients is associated with an increase in the degree of anal incontinence in the early post-operative period. Botulinum Toxin Type A application in complex treatment of patients with chronic anal fissure (after fissure excision) is intended to improve the therapy results, namely to reduce the frequency and duration of anal sphincter insufficiency after sphincter spasm removal (reduction in the number of patients suffering from post-operative incontinence). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03855046
Study type Interventional
Source State Scientific Centre of Coloproctology, Russian Federation
Contact Evgeny E. Zharkov, MD
Phone 89039689739
Email drzharkov@mail.ru
Status Recruiting
Phase Phase 4
Start date September 1, 2019
Completion date November 1, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04604483 - Percutaneous Tibial Nerve Stimulation (PTNS) for the Treatment of Chronic Anal Fissure N/A
Completed NCT05837403 - The Use of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure Phase 3
Recruiting NCT02419534 - Pediatrics Anal Fissures Treatment With Polyethylene Glycol Phase 4
Recruiting NCT05590520 - Comparison of Injections of Botulinum Toxin and Topical Nitroglycerin Ointment for the Treatment of Chronic Anal Fissure N/A
Withdrawn NCT03105674 - Multi-Drug Analgesia vs. Standard Solution for Anal Surgery Phase 4
Completed NCT05993793 - Use of Fototherapy in the Treatment of Fissure in Ano N/A
Not yet recruiting NCT04887818 - Diltiazem Ointment With Lidocaine vs. Nifedipine Ointment With Lidocaine Ointment for Treatment of Chronic Anal Fissure Phase 2/Phase 3
Completed NCT02402543 - Pre-Emptive Analgesia in Ano-Rectal Surgery N/A
Completed NCT05091775 - The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure Phase 1/Phase 2
Unknown status NCT00328900 - Measurement of Stress During Anesthesia With "Pain Detector" on Patients Receiving Atropine N/A
Not yet recruiting NCT04714684 - The Role of Fitostimoline Proctogel in Symptoms Relief and Healing in Patients Affected by Anal Fissure N/A
Completed NCT03405922 - Perianal Nerval Block in Proctological Interventions Phase 4
Completed NCT00522041 - A Study to Determine the Effect of Nitroglycerin Ointment on the Pain Associated With Chronic Anal Fissures Phase 3